The aberrant splicing of CDKN3 (cyclin-dependent kinase inhibitor 3) mRNA in human gliomas generated a dominant negative CDKN3 variant and the CDKN3 over expression correlated with decreased patient survival [31]. Here, CDKN3 is linked to central nervous system cancer.